Impact of ibrutinib dose intensity on patient outcomes in previously treated Waldenstrom macroglobulinemia

被引：16
|
作者：
Castillo, Jorge J. [1 ,2 ]
Gustine, Joshua N. [1 ]
Meid, Kirsten [1 ]
Dubeau, Toni E. [1 ]
Xu, Lian [1 ]
Yang, Guang [1 ,2 ]
Hunter, Zachary R. [1 ]
Advani, Ranjana [3 ]
Palomba, Lia [4 ]
Treon, Steven P. [1 ,2 ]
机构：
[1] Dana Farber Canc Inst, Bing Ctr Waldenstrom Macroglobulinemia, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
[4] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
HAEMATOLOGICA | 2018年 / 103卷 / 10期
关键词：
MYD88;
D O I：
10.3324/haematol.2018.191999
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E466 / E468
页数：3
相关论文
共 50 条
  • [1] Impact of Ibrutinib Dose Intensity on Patient Outcomes in Previously Treated Waldenstrom Macroglobulinemia
    Gustine, Joshua
    Meid, Kirsten
    Dubeau, Toni
    Severns, Patricia
    Treon, Steven P.
    Castillo, Jorge J.
    BLOOD, 2017, 130
  • [2] Ibrutinib in Previously Treated Waldenstrom's Macroglobulinemia
    Treon, Steven P.
    Tripsas, Christina K.
    Meid, Kirsten
    Warren, Diane
    Varma, Gaurav
    Green, Rebecca
    Argyropoulos, Kimon V.
    Yang, Guang
    Cao, Yang
    Xu, Lian
    Patterson, Christopher J.
    Rodig, Scott
    Zehnder, James L.
    Aster, Jon C.
    Harris, Nancy Lee
    Kanan, Sandra
    Ghobrial, Irene
    Castillo, Jorge J.
    Laubach, Jacob P.
    Hunter, Zachary R.
    Salman, Zeena
    Li, Jianling
    Cheng, Mei
    Clow, Fong
    Graef, Thorsten
    Palomba, M. Lia
    Advani, Ranjana H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (15): : 1430 - 1440
  • [3] Ibrutinib and Venetoclax in Previously Untreated Waldenstrom Macroglobulinemia
    Castillo, Jorge J.
    Sarosiek, Shayna
    Branagan, Andrew R.
    Sermer, David J.
    Flynn, Catherine A.
    Leventoff, Carly
    Little, Megan
    White, Timothy P.
    Meid, Kirsten
    Canning, Alexa
    Guerrera, Maria Luisa
    Kofides, Amanda
    Liu, Xia
    Munshi, Manit
    Tsakmaklis, Nicholas
    Patterson, Christopher J.
    Hunter, Zachary R.
    Treon, Steven P.
    BLOOD, 2022, 140
  • [4] Ventricular Tachycardia Storm in a Patient Treated With Ibrutinib for Waldenstrom Macroglobulinemia
    Madgula, Anantha Sriharsha
    Singh, Meghana
    Almnajam, Mansour
    Pickett, Christopher C.
    Kim, Agnes S.
    JACC: CARDIOONCOLOGY, 2020, 2 (03): : 523 - 526
  • [5] Plasmablastic lymphoma transformation in a patient with Waldenstrom macroglobulinemia treated with ibrutinib
    Castillo, Jorge J.
    LaMacchia, John
    Flynn, Catherine A.
    Sarosiek, Shayna
    Pozdnyakova, Olga
    Treon, Steven P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (03) : 466 - 468
  • [6] Venetoclax in Previously Treated Waldenstrom Macroglobulinemia
    Castillo, Jorge J.
    Allan, John N.
    Siddiqi, Tanya
    Advani, Ranjana H.
    Meid, Kirsten
    Leventoff, Carly
    White, Timothy P.
    Flynn, Catherine A.
    Sarosiek, Shayna
    Branagan, Andrew R.
    Demos, Maria G.
    Guerrera, Maria L.
    Kofides, Amanda
    Liu, Xia
    Munshi, Manit
    Tsakmaklis, Nicholas
    Xu, Lian
    Yang, Guang
    Patterson, Christopher J.
    Hunter, Zachary R.
    Davids, Matthew S.
    Furman, Richard R.
    Treon, Steven P.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (01) : 63 - +
  • [7] PATIENT-REPORTED OUTCOMES (PROS) WITH IBRUTINIB: SUBSTUDY OF INNOVATETM FOR WALDENSTROM MACROGLOBULINEMIA (WM)
    Trotman, J.
    Dimopoulos, M. A.
    Tedeschi, A.
    Matous, J. V.
    Heffner, L. T.
    Shustik, C.
    Garcia-Sanz, R.
    Castillo, J. J.
    Leblond, V.
    Kastritis, E.
    Li, J.
    Graef, T.
    Bilotti, E.
    Buske, C.
    HAEMATOLOGICA, 2017, 102 : 510 - 510
  • [8] Ibrutinib Discontinuation in Waldenstrom Macroglobulinemia: Etiologies, Outcomes, and IgM Rebound
    Gustine, Joshua
    Meid, Kirsten
    Dubeau, Toni
    Severns, Patricia
    Xu, Lian
    Hunter, Zachary
    Treon, Steven P.
    Castillo, Jorge J.
    BLOOD, 2017, 130
  • [9] Ibrutinib discontinuation in Waldenstrom macroglobulinemia: Etiologies, outcomes, and IgM rebound
    Gustine, Joshua N.
    Meid, Kirsten
    Dubeau, Toni
    Severns, Patricia
    Hunter, Zachary R.
    Guang, Yang
    Xu, Lian
    Treon, Steven P.
    Castillo, Jorge J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (04) : 511 - 517
  • [10] IBRUTINIB IN A PATIENT WITH WALDENSTROM MACROGLOBULINEMIA AND ACQUIRED VON WILLEBRAND DISEASE
    Garcia Rodrigo, Iniguez
    Santaella Maria, Poza
    Herrero Irene, Zamanillo
    Guerrero Elena, Vera
    Soto Marta, Hidalgo
    Munoz Nieves, Lopez
    Alos Daniel, Gil
    Manso Rodrigo, Gil
    Gil Rafael, Colmenares
    Ubieto Ana, Jimenez
    Lopez Joaquin, Martinez
    HAEMATOLOGICA, 2021, 106 (10) : 343 - 344
12345